Paul David Zito, MBBS

Paul Zito practices at Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma.

Paul Zito's NPI, 1396155966, was assigned on May 5, 2014. Paul Zito graduated from University of Sydney Faculty of Medicine in 2012. Paul Zito's Texas license number on file is R3253.

Paul Zito's primary practice is Oklahoma Cancer Specialists and Research Institute, at 12697 E 51st S St, Tulsa, OK 74146 in Tulsa County. The practice phone is (918) 505-3200.

Paul Zito's primary practice is Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma. Paul Zito is also affiliated with Saint Francis Hospital. The medical group on file is Oklahoma Cancer Specialists and Research Institute. Dmand AI also links Paul Zito to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Zito practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Paul Zito's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Paul Zito is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Paul Zito's licenses on file in 3 states: Texas, Oklahoma and Louisiana.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, lung cancer and lymphoma among the conditions Paul Zito treats.

CMS data shows 144,452 Medicare services from Paul Zito across 91 procedure codes in 2024, for 997 Medicare patients. Medicare paid $2,161,183 for them.

CMS counts 997 Medicare patients who saw Paul Zito in 2024. The largest group is 65 to 74, with 451 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Paul Zito's median patient age at 70, with 64% women.

In 2024, Paul Zito wrote 2,374 Medicare Part D claims for 351 patients. 82% of them were for generic drugs. CMS names the drug for 2,015 of them, across 50 drugs with 11 or more claims each, at $3,358,786 in total drug cost. In 2023, CMS named 1,425 claims across 39 drugs.

Paul Zito accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 178 general payments to Paul Zito from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Pfizer Inc. paid the most, $566.

Paul Zito graduated from University of Sydney Faculty of Medicine in 2012.

Paul Zito is in network with 24 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.